Overview
Hydranencephaly is a rare and severe congenital condition in which the cerebral hemispheres of the brain are absent and replaced by sacs filled with cerebrospinal fluid. The brainstem, cerebellum, and other subcortical structures are typically preserved, which allows basic life-sustaining functions such as breathing, heart rate regulation, and some reflexive responses to continue. The condition is thought to result primarily from bilateral internal carotid artery occlusion or other vascular insults during fetal development, leading to massive destruction of previously formed brain tissue. Other proposed causes include intrauterine infections (such as toxoplasmosis or cytomegalovirus), genetic factors, or other teratogenic exposures. Hydranencephaly is sometimes referred to as hydranencephaly syndrome. At birth, infants with hydranencephaly may initially appear normal, as the head size can be within normal range or only mildly enlarged. However, within weeks to months, affected infants typically develop signs of increased intracranial pressure, progressive macrocephaly (enlargement of the head), irritability, spasticity, seizures, and severe developmental delay. Vision is usually absent or severely impaired, and most infants fail to achieve developmental milestones. Feeding difficulties are common, and many affected children require gastrostomy tube placement for nutritional support. The condition primarily affects the central nervous system, but secondary complications can involve the musculoskeletal system (contractures), respiratory system, and gastrointestinal system. There is no cure for hydranencephaly, and treatment is supportive and symptomatic. Management may include placement of a ventriculoperitoneal shunt to relieve hydrocephalus and control head enlargement, anticonvulsant medications for seizure management, physical therapy, and nutritional support. The prognosis is generally poor, with many affected infants not surviving beyond the first year of life, although some individuals have survived into childhood or rarely beyond with intensive supportive care. Early diagnosis is typically made through prenatal ultrasound or postnatal neuroimaging such as cranial ultrasound, CT scan, or MRI, which reveals the characteristic absence of cerebral hemispheres.
Clinical phenotype terms— hover any for plain English:
Sporadic
Usually appears on its own, not inherited from a parent
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Hydranencephaly.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Hydranencephaly at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Hydranencephaly.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Hydranencephaly.
Community
No community posts yet. Be the first to share your experience with Hydranencephaly.
Start the conversation →Latest news about Hydranencephaly
No recent news articles for Hydranencephaly.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Hydranencephaly
What is Hydranencephaly?
Hydranencephaly is a rare and severe congenital condition in which the cerebral hemispheres of the brain are absent and replaced by sacs filled with cerebrospinal fluid. The brainstem, cerebellum, and other subcortical structures are typically preserved, which allows basic life-sustaining functions such as breathing, heart rate regulation, and some reflexive responses to continue. The condition is thought to result primarily from bilateral internal carotid artery occlusion or other vascular insults during fetal development, leading to massive destruction of previously formed brain tissue. Othe
How is Hydranencephaly inherited?
Hydranencephaly follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Hydranencephaly typically begin?
Typical onset of Hydranencephaly is neonatal. Age of onset can vary across affected individuals.